Anji is a technology transfer professional with more than 18 years’ experience of working with early-stage translational research. Anji has extensive experience of IP and contract management, IP transactions and business development of healthcare technologies and development of knowledge transfer policies. Her current role at LifeArc involves working with academic and charitable establishments to identify, cultivate and commercialise early-stage healthcare technologies. Anji provides specialist advice in the areas of research commercialisation, intellectual property and commercial negotiations to charity, small commercial partners, and the LifeArc Philanthropic Fund, which is designated to fund early- stage translational developments that address rare diseases.
As a proponent for professional advancement in technology transfer, Anji developed and leads the LifeArc-AUTM Technology Transfer Training Fellowship programme. This collaborative initiative with AUTM, is designed to train and assist scientists to become technology transfer professionals. Anji also directs STEM programmes allowing students from underrepresented backgrounds to learn about Life Science related careers and gain experience in scientific laboratories and innovation departments.
An advocate of equality diversity and Inclusion (EDI), Anji cofounded Global Equality, Diversity and Equality in Technology Transfer (GEDITT), an initiative with a mission to raise awareness and promote EDI in the technology transfer sector.
Previous roles include Intellectual Property, Contract, Technology Transfer and Business Development positions at the Wellcome Trust, St George’s University London and Thomson Pharma.
Anji holds an M.Sc. in Human Molecular Genetics and Ph.D. in Cancer Genetics from Imperial College, as well as an M.Sc. and Certificate in Intellectual Property Law from Queen Mary, University of London. She is a certified project manager (PRINCE2), registered technology transfer professional (RTTP) and a certified licensing professional (CLP).
Anji sits on the boards of AUTM, ASTP, and is a member of: the BioIndustry Association (BIA) Cell & Gene Therapy Advisory Committee, and AUTM Equity, Diversity & Inclusion Committee.
Thank you for reading my story and visiting my page.
Don’t miss the chance to be part of our growing ecosystem.